G-29701 structure
|
Common Name | G-29701 | ||
|---|---|---|---|---|
| CAS Number | 129-20-4 | Molecular Weight | 324.37400 | |
| Density | 1.241g/cm3 | Boiling Point | 485.6ºC at 760mmHg | |
| Molecular Formula | C19H20N2O3 | Melting Point | 109-111°C | |
| MSDS | Chinese USA | Flash Point | 247.5ºC | |
| Symbol |
GHS07, GHS09 |
Signal Word | Warning | |
Use of G-29701Oxyphenbutazone is a phenylbutazone derivative, with anti-inflammatory effect. Oxyphenbutazone is a non-selective COX inhibitor. Oxyphenbutazone selectively kills non-replicating Mycobaterium tuberculosis[1][2]. |
| Name | oxyphenbutazone |
|---|---|
| Synonym | More Synonyms |
| Description | Oxyphenbutazone is a phenylbutazone derivative, with anti-inflammatory effect. Oxyphenbutazone is a non-selective COX inhibitor. Oxyphenbutazone selectively kills non-replicating Mycobaterium tuberculosis[1][2]. |
|---|---|
| Related Catalog | |
| Target |
COX[1] |
| In Vitro | Oxyphenbutazone enhances the anticancer efficiency of methotrexate (MTX) in Hep3B cells[1]. Oxyphenbutazone (2.5 -7.5 µM; 48 hours) co-treatment with (MTX, 0.25-1.0 µM) shows potential cytotoxicity against Hep3B cells[1]. Oxyphenbutazone exhibits reparative effects in the hepatocytes[1]. Cell Cytotoxicity Assay[1] Cell Line: Hep3B cells Concentration: 2.5 µM, 5 µM, 7.5 µM Incubation Time: 48 hours Result: Enhanced the cytotoxicity of MTX. |
| In Vivo | Oxyphenbutazone (70 mg/kg/week; p.o.; in two divided doses; for 13 weeks) exerts potential anticancer activity when co-treatment with MTX (5.0 or 2.5 mg/kg/week; i.p.)[1]. Animal Model: 5–6 weeks Wistar strain albino male rats (150–220 g)[1] Dosage: 70 mg/kg/week (co-treatment with MTX 5.0 or 2.5 mg/kg/week) Administration: Oral administration; once a week; in two divided doses; for 13 weeks Result: Exerted potential anticancer activity in rats when co-treatment with MTX. |
| References |
| Density | 1.241g/cm3 |
|---|---|
| Boiling Point | 485.6ºC at 760mmHg |
| Melting Point | 109-111°C |
| Molecular Formula | C19H20N2O3 |
| Molecular Weight | 324.37400 |
| Flash Point | 247.5ºC |
| Exact Mass | 324.14700 |
| PSA | 60.85000 |
| LogP | 3.62340 |
| Vapour Pressure | 4.7E-10mmHg at 25°C |
| Index of Refraction | 1.61 |
| Storage condition | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
|
~%
G-29701 CAS#:129-20-4 |
| Literature: Helvetica Chimica Acta, , vol. 40, p. 395,399 |
|
~%
G-29701 CAS#:129-20-4 |
| Literature: Helvetica Chimica Acta, , vol. 40, p. 395,399 |
|
~%
G-29701 CAS#:129-20-4 |
| Literature: Helvetica Chimica Acta, , vol. 40, p. 395,399 |
|
~%
G-29701 CAS#:129-20-4 |
| Literature: Helvetica Chimica Acta, , vol. 40, p. 395,399 |
|
~%
G-29701 CAS#:129-20-4 |
| Literature: Helvetica Chimica Acta, , vol. 40, p. 395,399 |
|
~%
G-29701 CAS#:129-20-4 |
| Literature: Helvetica Chimica Acta, , vol. 40, p. 395,399 |
|
~%
G-29701 CAS#:129-20-4 |
| Literature: Helvetica Chimica Acta, , vol. 40, p. 395,399 |
|
~%
G-29701 CAS#:129-20-4 |
| Literature: Experientia, , vol. 15, p. 95 |
|
~%
G-29701 CAS#:129-20-4
Detail
|
| Literature: Journal of Pharmaceutical Sciences, , vol. 70, # 4 p. 460 - 461 |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I.
Adverse Drug React. Acute Poisoning Rev. 5(2) , 97-136, (1986)
|
|
|
Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II.
Adverse Drug React. Acute Poisoning Rev. 5(3) , 181-96, (1986)
|
|
|
Disposition and tolerance of suxibuzone in horses.
Equine Vet. J. 31(5) , 411-6, (1999) Suxibuzone (SBZ), a nonsteroidal anti-inflammatory drug, was administered to 6 horses at a dose rate of 7.5 mg/kg bwt by intravenous (i.v.) route. Plasma and synovial fluid concentrations of suxibuzon... |
| p-Oxyphenylbutazone |
| oxyphenbutazon |
| 4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione |
| 4-Butyl-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione G 27202 |
| Oxazolidin |
| ossifenbutazone |
| EINECS 204-936-2 |
| oxyphenylbutazone |
| MFCD00057278 |
| Idrobutazina |
| Oxyphenbutazone |
| Tanderil |
| Oxiphenbutazone |
| Oxi-Fenibutol |
| Oxifenylbutazon |
| Etrozolidina |